Skip to main content

Syndax Pharmaceuticals Inc 10-Q for FY2023 Q1

Syndax Pharmaceuticals Inc (SNDX)

10-Q 2023-05-08 For: 2023-03-31
View Original
Added on April 09, 2026

About this 10-Q

Syndax Pharmaceuticals Inc filed this 10-Q on May 8, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).

Headline figures

Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$41.13M
compared with a net loss of $37.17M a year earlier
Diluted EPS
-$0.59
compared with -$0.63 a year earlier